Source Bioscience acquires Cambridge Clinical Laboratories
Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition ...
Tag: Preclinical
Tim-3 identified as promising therapeutic target for Alzheimer's disease
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its ...
Triple therapy reduces tumor burden and improves survival in glioblastoma models
A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy ...
Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumors
B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common ...
Groundbreaking stem cell therapy trial for Alzheimer's disease underway at UTHealth Houston
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston. In ...
Combination of RAS inhibition and immunotherapy provides breakthrough for pancreatic cancer
Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic ...
Insilico Medicine's AI-driven drug Rentosertib receives official generic name
Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic ...
Microphysiological systems in drug discovery
What are the challenges of drug development? Drug development is a very challenging and often arduous process with many associated ...
Neurofilament light as a translational biomarker from preclinical drug discovery to clinical application
In this interview, industry expert Phillip Mitchell discusses the role of NfL biomarkers in CNS drug discovery, neurodegenerative disease research, ...
Researchers discover strategy to slow brain metastases growth in melanoma
Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers at ...